NO124688B - - Google Patents
Download PDFInfo
- Publication number
- NO124688B NO124688B NO169490A NO16949067A NO124688B NO 124688 B NO124688 B NO 124688B NO 169490 A NO169490 A NO 169490A NO 16949067 A NO16949067 A NO 16949067A NO 124688 B NO124688 B NO 124688B
- Authority
- NO
- Norway
- Prior art keywords
- dione
- chloro
- bismethylene
- solution
- acetate
- Prior art date
Links
- 238000000034 method Methods 0.000 claims description 7
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 239000000460 chlorine Chemical group 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 125000001153 fluoro group Chemical group F* 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical group ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 238000001953 recrystallisation Methods 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 5
- 239000005457 ice water Substances 0.000 description 5
- 230000007017 scission Effects 0.000 description 5
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000583 progesterone congener Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 229910000104 sodium hydride Inorganic materials 0.000 description 3
- 239000012312 sodium hydride Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- BPLKQGGAXWRFOE-UHFFFAOYSA-M trimethylsulfoxonium iodide Chemical compound [I-].C[S+](C)(C)=O BPLKQGGAXWRFOE-UHFFFAOYSA-M 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- -1 1,2-methylene compounds Chemical class 0.000 description 2
- MNRGTYIVYMTMKH-UHFFFAOYSA-N 2-sulfinylpropane Chemical compound CC(C)=S=O MNRGTYIVYMTMKH-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 150000002168 ethanoic acid esters Chemical class 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005822 methylenation reaction Methods 0.000 description 2
- 239000012053 oil suspension Substances 0.000 description 2
- 230000016087 ovulation Effects 0.000 description 2
- 229940095055 progestogen systemic hormonal contraceptives Drugs 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- LOVNYFVWYTXDRE-WMSSUOLPSA-N 16-Hydroxyprogesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC(O)[C@H](C(=O)C)[C@@]1(C)CC2 LOVNYFVWYTXDRE-WMSSUOLPSA-N 0.000 description 1
- RILZRCJGXSFXNE-UHFFFAOYSA-N 2-[4-(trifluoromethoxy)phenyl]ethanol Chemical compound OCCC1=CC=C(OC(F)(F)F)C=C1 RILZRCJGXSFXNE-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZRKWMRDKSOPRRS-UHFFFAOYSA-N N-Methyl-N-nitrosourea Chemical compound O=NN(C)C(N)=O ZRKWMRDKSOPRRS-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 231100000546 inhibition of ovulation Toxicity 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000001035 methylating effect Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000000757 progestagenic effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DESC039449 | 1966-08-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO124688B true NO124688B (it) | 1972-05-23 |
Family
ID=7435178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO169490A NO124688B (it) | 1966-08-25 | 1967-08-24 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3480711A (it) |
| BE (1) | BE703084A (it) |
| CH (1) | CH518272A (it) |
| CS (1) | CS150193B2 (it) |
| DE (1) | DE1593516C3 (it) |
| DK (1) | DK114972B (it) |
| ES (1) | ES344167A1 (it) |
| FI (1) | FI45170C (it) |
| GB (1) | GB1136856A (it) |
| IL (1) | IL28466A (it) |
| NL (1) | NL152564B (it) |
| NO (1) | NO124688B (it) |
| SE (1) | SE325270B (it) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1643027B2 (de) * | 1967-06-09 | 1977-12-08 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | 4,6-dichlor-delta hoch 4,6- steroide der pregnanreihe |
| DK123712B (da) * | 1969-02-13 | 1972-07-24 | Schering Ag | Analogifremgangsmåde til fremstilling af 4-chlor-1α, 2α, 6α, 7α-dimethylen-4-pregnen-17α-ol-3,20-dion eller estere deraf. |
| US5374035A (en) * | 1993-06-03 | 1994-12-20 | Santos; Jose C. | Winch with power train, manual operation option, and particular brake assembly |
| DE102007027635A1 (de) * | 2007-06-12 | 2008-12-18 | Bayer Schering Pharma Aktiengesellschaft | 17ß-Cyano-19-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1183500B (de) * | 1962-10-12 | 1964-12-17 | Schering Ag | Verfahren zur Herstellung von alpha, beta-Methylenketonen der Steroidreihe |
-
1966
- 1966-08-25 DE DE1593516A patent/DE1593516C3/de not_active Expired
-
1967
- 1967-06-30 SE SE10021/67*A patent/SE325270B/xx unknown
- 1967-07-18 CS CS5275A patent/CS150193B2/cs unknown
- 1967-08-02 US US657749A patent/US3480711A/en not_active Expired - Lifetime
- 1967-08-07 IL IL28466A patent/IL28466A/en unknown
- 1967-08-11 CH CH1133367A patent/CH518272A/de not_active IP Right Cessation
- 1967-08-11 DK DK409167AA patent/DK114972B/da unknown
- 1967-08-16 ES ES344167A patent/ES344167A1/es not_active Expired
- 1967-08-21 GB GB38441/67A patent/GB1136856A/en not_active Expired
- 1967-08-24 NO NO169490A patent/NO124688B/no unknown
- 1967-08-24 FI FI672277A patent/FI45170C/fi active
- 1967-08-24 NL NL676711628A patent/NL152564B/xx not_active IP Right Cessation
- 1967-08-25 BE BE703084D patent/BE703084A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI45170C (fi) | 1972-04-10 |
| DK114972B (da) | 1969-08-25 |
| CH518272A (de) | 1972-01-31 |
| BE703084A (it) | 1968-02-26 |
| NL152564B (nl) | 1977-03-15 |
| IL28466A (en) | 1971-11-29 |
| GB1136856A (en) | 1968-12-18 |
| DE1593516B2 (de) | 1974-09-19 |
| ES344167A1 (es) | 1968-09-16 |
| CS150193B2 (it) | 1973-09-04 |
| NL6711628A (it) | 1968-02-26 |
| SE325270B (it) | 1970-06-29 |
| FI45170B (it) | 1971-12-31 |
| DE1593516A1 (de) | 1970-12-03 |
| US3480711A (en) | 1969-11-25 |
| DE1593516C3 (de) | 1975-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3128283A (en) | 17-oxygenated oxa-steroids and intermediates thereto | |
| US3682983A (en) | Preparation of {66 {11 {11 -17 ethinyl steroids | |
| US4119625A (en) | Process for the manufacture of steroid carboxylic acids and the esters thereof | |
| NO124688B (it) | ||
| US3170934A (en) | Unsaturated 19-oxygenated 3-oxosteroids and process for their manufacture | |
| US3210388A (en) | 13alpha-fluoro-17beta-methyl-18-nor steroids | |
| Djerassi et al. | Terpenoids. XVI. 1 The Constitution of the Cactus Triterpene Cochalic Acid. Partial Reductions of Methyl Diketoechinocystate2 | |
| Greenhalgh et al. | 445. Studies in the sterol group. Part LIII. The preparation of 7-hydroxy-3-keto-Δ 4-steroids | |
| US3637770A (en) | Process for the production of 16alpha 17alpha-dihydroxy-19-nor-progesterone | |
| US3436390A (en) | 4,4-dihydroxy-2-butenoic acid lactones | |
| US3639392A (en) | Cardioactive oxido-bufatrienolides | |
| US2716125A (en) | 3(beta)-acetoxy-16(delta-acetoxyisocaprooxy)-allopregnanedione-11, 20 | |
| US2727907A (en) | Derivatives of 16-alkanoyloxy-17alpha-hydroxypregnen-20-ones | |
| US2782212A (en) | 14-methyl pregnenes and method | |
| US2862011A (en) | Production of 2-bromo-keto-11-oxygenated-4,17-(20)-pregnadiene-21-oic acid esters | |
| US3138617A (en) | Processes for the production of 19-nor-delta4-[9beta], [10alpha]-androstenes and intermediates | |
| US3096350A (en) | 6, 16alpha-dimethyl-delta1, 4, 6-pregnatriene-17alpha-ol-3, 20-dione and esters thereof | |
| US3485829A (en) | Cyclobutano- and cyclobuteno-(3',4':6,7) derivatives of the androstane and 19-nor-androstane series | |
| US2562030A (en) | Production of 17-hydroxy 20-keto steroid compounds | |
| US3574688A (en) | Unsaturated 2-oxa steroid derivatives and process for their preparation | |
| US3414565A (en) | 3, 5-cyclo-6beta, 19-oxido steroids and processes for their preparation | |
| US3287356A (en) | Dihaloalkylation of keto steroids | |
| US3145200A (en) | Steroido[3.2-c]isoxazoles and preparation thereof | |
| US3300518A (en) | 17alpha-trifluorovinyl androstenes | |
| US2683723A (en) | Steroid alkali-metal enolates |